Aberrant intra-epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103-beta7-receptor-mediated granzyme-B degranulation which can be restored by etrolizumab.
Castelijn DAR, van de Water JMW, de Baaij LR, McGlinchy BS, van Leeuwen M, Joosten SPJ, Alberts N, Rossi M, Reijm M, Hollander JC, Bonnet P, Kooy-Winkelaar YMC, Koning F, Pals ST, Bouma G, Meijer CJLM, Bontkes HJ, Mulder CJJ, Cillessen SAGM.
Castelijn DAR, et al.
Clin Transl Immunology. 2026 May 14;15:e70099. doi: 10.1002/cti2.70099. eCollection 2026.
Clin Transl Immunology. 2026.
PMID: 42146106
Free PMC article.
OBJECTIVES: Refractory celiac disease type II (RCDII) is an intestinal tumor of aberrant intra-epithelial T-lymphocytes (IEL). ...RESULTS: Levels of granzyme-B expression were significantly upregulated in aberrant IEL of RCDII patients compared …
OBJECTIVES: Refractory celiac disease type II (RCDII) is an intestinal tumor of aberrant intra-epithelial T-lymphocy …